Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants

NCT07363837 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus (RSV)

Interventions

DRUG: SIBP-A16 injection
DRUG: Nirsevimab
DRUG: SIBP-A16 buffer solution

Sponsor

Shanghai Institute Of Biological Products